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Abstract
Aims Heart failure (HF) patients are taught to identify a rapid 5 lb body-weight gain for early detection of cardiac decom-
pensation. Few data support this common advice. The study aim was to determine whether a 5 lb weight gain in 1 week
and signs and symptoms of HF increased risk for unplanned physician or emergency department (ED) visits or hospital admis-
sion in rural HF patients.
Methods and results This was a secondary analysis of a randomized trial. Patients tracked body weight and HF symptoms
using diaries. We included patients adherent to daily diaries >50% over 24 months (N = 119). Mean age was 69 ± 11 years;
77% (65) were male, and 67% completed diaries. A weight gain of 5 lb over 7 days was associated with a greater risk for
ED visits but not hospital admission [hazard ratio (HR) 1.06, 95% confidence interval (CI) 1.04, 1.08; P < 0.0001 vs. HR
1.01, 95% CI 0.88, 1.16; P = 0.79]. Increased dyspnoea over 7 days was associated with a greater risk of ED visits and hospital
admissions (HR 9.64, 95% CI 3.68, 25.22; P < 0.0001 vs. HR 5.89, 95% CI 1.73, 20.04; P = 0.01). Higher diary adherence was
associated with older age, non-sedentary behaviour, lower depression, and HF knowledge.
Conclusions Heart failure patients are counselled to observe for body-weight gain. Our data do not support that a 5 lb
weight gain was associated with hospital admission. Dyspnoea was a better predictor of ED visits and hospital admissions.
Daily tracking of dyspnoea symptoms may be an important adjunct to daily weight to prevent hospitalization.
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Introduction
Ubiquitous to the heart failure (HF) clinic visit is the advice
that patients contact their providers if they experience a
body-weight gain of 5 lb in 1 week.1,2 Guidelines for the Heart
Failure Society of America and the European Society for Heart
Failure both endorse patient education to improve outcomes
for patients with HF.3,4 However, content-specific HF patient
education regarding body weight, such as amount of weight
gain, over what time period, and whether weight gain applies
to all patients with HF has not been sufficiently investigated.
Additional patient education includes tracking of dys-
pnoea and oedema. Dyspnoea is a common subjective
finding in patients with HF. However, few data describe
whether increases in dyspnoea predict hospital admission
or emergency department (ED) visits. Oedema is a variable
clinical sign influenced by factors such as body position, nu-
tritional status, and dietary sodium intake. It is also unclear
if increases in oedema alone or in combination with other
HF signs and symptoms signify concern for unplanned phy-
sician office visits, ED visits, or hospital admission. Further,
no head-to-head analysis has been undertaken to deter-
mine whether body-weight gain or HF symptoms, such as
dyspnoea or oedema, are better at predicting outcomes
such as unplanned physician office visits, ED visits, or hos-
pital admission.
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Heart failure-specific guidelines extol the virtue of HF self-
management as an important strategy for improving
outcomes.3,4 One such method for self-management can
include the use of calendars or diaries. Daily diary use can
provide an opportunity for providers and patients to mutu-
ally engage in body weight and HF symptom tracking over
time.5 Electronic diaries and mobile phone app use have
quickly grown over the past decade to support patient
engagement in diary use for many chronic conditions.6,7 HF
patients are often instructed to routinely record daily body
weight and HF symptoms such as dyspnoea, pillow use,
and presence of oedema in their diaries.8,9 However, few
data demonstrate that tracking weight and HF symptoms
improve long-term patient outcomes.10
A challenging aspect of the HF patient clinic visit is to pro-
vide patients with evidence-driven education to support their
self-management efforts. Numerous investigators have de-
veloped diary interventions that follow patient experiences
such as food intake, mood, and medication use.5,11 Data
show that the use of diaries can improve self-management
skills and clinical outcomes, such as depression, as well as de-
crease the incidence of medication errors.5,11
Investigators have determined that memory recall for HF
patient body weight is unreliable.12 If diary data demonstrate
that a rapid weight gain of 5 lb can predict poor outcomes,
then patient education will be data driven and justify daily
tracking of body weight. The aim of this secondary analysis
of Rural Education to Improve Outcomes in Heart Failure
(REMOTE-HF) diary data was to determine whether a weight
gain of 5 lb increased risk of poor clinical outcomes, namely,
unplanned physician office visits, ED visits, and HF-related
hospital readmission in rural HF participants.8 We hypothe-
sized that participants who had a body-weight gain of 5 lb
over 1 week would have a higher risk of unplanned office
visits, ED visits, and HF-related hospital readmissions. Our
second aim was to determine which, if any, signs and symp-
toms of HF exacerbation, namely, dyspnoea and oedema, in-
creased risk for poor clinical outcomes.
Methods
Design and sample
The parent study for our secondary analysis was the
REMOTE-HF randomized controlled clinical trial with three
arms: control and two intervention arms (Fluid Watcher’s
LITE and PLUS).8 Both intervention groups included the same
nurse-delivered in-person education session that focused on
self-care and the use of daily body weight and symptom dia-
ries. Reinforcement of self-care education for the LITE group
included two follow-up phone calls. The PLUS intervention
group received reinforcement of self-care education with bi-
weekly phone calls until the nurse considered the participant
sufficiently understood, and could repeat back, the educa-
tional information (mean 5.3 + 3.6, range 1–19). The educa-
tion intervention (LITE or PLUS groups) did not decrease the
combined endpoint of cardiac death or hospitalization for
HF. Cardiac mortality was significantly lower for participants
in the LITE group over the 2 years of follow-up.
Eligibility for the study included age ≥ 18 years, rural home
address, hospitalized for HF within the past 6 months, English
proficiency, and living independently (Figure 1). Participant
recruitment took place in 12 clinics or hospitals in California,
Kentucky, and Nevada. Institutional Review Board approval
was obtained at the three major participating sites, and 602
Figure 1 Study flow diagram.
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participants were enrolled. Exclusion criteria included serious
comorbidity (i.e. disease or illness predicted to cause death
within 12 months), current participation in a HF disease man-
agement programme, or impaired cognition. Participants
were randomized after completing baseline testing, and ran-
dom selection techniques with 1:1:1 fixed allocation random-
ization were employed using blocks of five participants (SPSS
18.0, Chicago, IL, USA). Blinding to group assignment took
place among all investigators, participants’ physicians, and re-
search assistants.
Procedures
All participants in the two intervention arms were instructed
to complete daily diaries for 24 months (The control arm did
not complete diaries.). The dairies were in calendar format
and had prompts to add data on daily body weight and HF
symptoms such as dyspnoea, number of pillows used for
sleep, and presence of oedema including the date and time
when symptoms began. All intervention participants received
digital scales with large numbers for improved visibility. If pa-
tients had HF-related health concerns, participants recorded
what type of action was required such as a physician’s office
phone call, ED visit, or other. If participants gained 5 lb in
7 days, they were instructed to call their physician’s office
using a provided script. Participants personally delivered dia-
ries at follow-up visits or returned diaries monthly via the
mail in self-addressed stamped envelopes during the 2 year
study period. All enrolled participants received large-print
questionnaires and diaries.
Study demographic data were collected face to face via a
standardized form and with structured questionnaires. De-
pression was measured with the 9-item Patient Health Ques-
tionnaire depression scale.13 HF knowledge was assessed
with a 20-item HF Knowledge Scale.14 The Charlson comor-
bidity index was used to assess the presence of participant
co-morbidities.15 At baseline, the 36-item Short Test of Func-
tional Health Literacy in Adults measured health literacy
using reading comprehension.16
Heart failure-related unplanned physician office visits, hos-
pital admissions, and cardiac and non-cardiac death were
assessed quarterly using the electronic medical record, physi-
cian contact, or by questioning participants. The cause of
death was determined by medical record review using a
blinded adjudication process, family interview, and physician
contact for out-of-hospital deaths.
Statistical analysis
Statistical analysis was performed using SAS (version 9.4, SAS
Institute Inc., Cary, NC, USA). Characteristics of the sample
and differences between participants who used diaries at
least 50% of the time vs. less than 50% of the time were
analysed using χ2 and Mann–Whitney U-tests. We employed
Cox proportional hazards models to determine whether a
body-weight gain of 5 lb increased risk of clinical outcomes
(unplanned office visits, ED visits, or hospital readmission)
in HF patients. To solve the potential problem that low adher-
ence to diary use was because of death, we used Cox models
with change in body weight and dyspnoea treated as time-
varying covariates (but included participants who used diaries
until their time of death). All two-sided significance levels
used were established a priori at 0.05. Cox proportional haz-
ards models with time-varying covariates were also utilized
for the secondary aim, to determine if dyspnoea and oedema
increased risk for office visits, ED visits, and hospital
admission.
Ethics
The ethical regulations of the study were consistent with the
principles outlined in the Declaration of Helsinki. Institutional
Review Board approval for ethics was obtained at all
three participating institutions in California, Kentucky, and
Nevada.17 Written informed consent to participate in the
study was obtained from all participants.
Results
Participant demographic and clinical
characteristics
We examined risk of events (unplanned office visits, ED visits,
and hospital admission) among 393 participants who partici-
pated in the intervention parent study and divided the group
by those who completed daily body weight and symptom
dairies at least 50% of the time (n = 119). We were unable
to examine risk of death as the rate of death was too low
to provide adequate hazard risk estimates. The parent study
participants’ New York Heart Association (NYHA) functional
classes were the following: NYHA I = 64 (10.6%), II = 325
(54.1%), III = 187 (31.1%), and IV = 25 (4.2%). When com-
bined, 212 (35.2%) of parent study participants had NYHA
functional class III/IV, similar to the 103 (38%) current study
participants’ III/VI functional class.
The mean age of the participants was 69 ± 11 years, 65%
were male, and 92% were White (Table 1). Twenty-one per
cent were employed, and 17% had not completed high
school. Slightly less than one-third (28%) had NYHA func-
tional class III or IV. We compared the participants who com-
pleted vs. did not complete daily diaries and found that older
age, non-sedentary behaviour, lower depression scores, and
lower HF knowledge scores were more often associated with
diary use at least 50% of the time.
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Body weight and symptoms in relation to
unplanned office visits
A body-weight gain of 5 lb over 7 days demonstrated lower
risk for physician office visits [hazard ratio (HR) 0.86, 95%
confidence interval (CI) 0.75, 0.98; P < 0.03], whereas an in-
crease in dyspnoea over 14 days (HR 5.05, 95% CI 1.12, 22.71;
P < 0.03), but not over 7 days (HR 2.51, 95% CI 0.31, 19.7;
P = 0.39), was associated with a greater risk for physician of-
fice visits (Table 2).
Body weight and symptoms in relation to
emergency department visits
A weight gain of 5 lb over 7 days was associated with greater
risk for ED visits (HR 1.06, 95% CI 1.04, 1.08; P < 0.0001),
but no greater risk was associatedwith weight gain of 5 lb over
14 days (HR 0.97, 95% CI 0.84, 1.12; P = 0.69). An increase in
dyspnoea at both 7 and 14 days (HR 9.64, 95% CI 3.68,
25.22; P< 0.0001; HR 9.87, 95% CI 2.76, 35.22; P< 0.0004; re-
spectively) was associated with a greater number of ED visits.
Table 1 Baseline characteristics of diary adherence
Clinical parameters (total = 393)
Diary users < 50%
of study days (n = 274)
Diary users ≥ 50%
of study days (n = 119) P value
Age, yearsa 65 ± 14 69 ± 11 0.004
Male 150 (55) 77 (65) 0.06
White 243 (89) 109 (92) 0.39
Not completed high school education 50 (18) 17 (14) 0.24
Employed 38 (14) 25 (21) 0.07
Married 153 (56) 68 (57) 0.81
BMI > 25 (kg/m2) 209 (76) 85 (71) 0.25
Sedentary 144 (53) 38 (32) <0.001
NYHA functional class III/IV 103 (38) 33 (28) 0.06
CABG 87 (32) 37 (31) 0.90
Current smoker 37 (14) 12 (10) 0.35
Hypercholesterolaemia 183 (67) 77 (65) 0.69
Arterial hypertension 215 (79) 93 (78) 0.94
Stroke 36 (13) 18 (15) 0.60
Anaemia 97 (35) 52 (44) 0.10
BNP (pg/mL) 387 ± 544 (268) 478 ± 1450 (108) 0.85
Creatinine (mg/dL) 1.18 ± 0.46 (273) 1.34 ± 0.94 0.37
Charlson comorbidity index score 3.28 ± 1.76 (274) 3.12 ± 1.63 0.49
PHQ-9 depression score 8.32 ± 6.66 (274) 4.49 ± 4.55 <0.0001
HF knowledge score 14 ± 2.43 (274) 13.3 ± 2.92 0.02
Cardiac death 27 (9.9) 11 (9) 0.85
Non-cardiac death 29 (10.6) 6 (5) 0.07
Hospital readmission 79 (28.8) 37 (31) 0.65
BMI, body mass index; BNP, brain natriuretic peptide; CABG, coronary artery bypass grafting; HF, heart failure; NYHA, New York Heart As-
sociation; PHQ, Patient Health Questionnaire.
Bold indicates significant findings.
P ≤ 0.05 is significant.
aData are presented as mean ± standard deviation, n (%).
Table 2 Risk of events: body weight and heart failure symptoms (n = 119)
Event outcome Predictor variable HR Lower CI (95%) Upper CI (95%) P value
Unplanned/unscheduled
physician visit
Weight gain of 5 lb in 14 days (n = 16) 1.95 0.81 1.12 0.58
Weight gain of 5 lb in 7 days (n = 16) 0.86 0.75 0.98 0.03
Dyspnoea increase in 14 days (n = 17) 5.05 1.12 22.71 0.03
Dyspnoea increase in 7 days (n = 16) 2.51 0.31 19.7 0.39
Peripheral oedema (n = 19) 1.6 0.44 5.9 0.46
ED visit Weight gain of 5 lb in 14 days (n = 23) 0.97 0.84 1.12 0.69
Weight gain of 5 lb in 7 days (n = 24) 1.06 1.04 1.08 <0.0001
Dyspnoea increase in 14 days (n = 25) 9.87 2.76 35.22 0.0004
Dyspnoea increase in 7 days (n = 25) 9.64 3.68 25.22 <0.0001
Peripheral oedema (n = 31) 2.62 1.14 6.00 0.02
Hospital admission Weight gain of 5 lb in 14 days (n = 24) 1.00 0.92 1.09 0.89
Weight gain of 5 lb in 7 days (n = 24) 1.01 0.88 1.16 0.79
Dyspnoea increase in 7 days (n = 25) 5.89 1.73 20.04 0.004
Dyspnoea increase in 14 days (n = 26) 3.67 1.15 11.70 0.03
Peripheral oedema (n = 30) 0.89 0.27 2.92 0.85
CI, 95% confidence intervals; ED, emergency department; HR, hazard ratio.
Bold indicates significant findings.
P ≤ 0.05 is significant.
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Peripheral oedema was also significantly associated with
greater risk for ED visits (HR 2.62, 95% CI 1.14, 6.00; P< 0.02).
Body weight and symptoms in relation to hospital
admission
An increase in body weight by 5 lb over 7 or 14 days was not
associated with greater risk of hospital admission (HR 1.01,
95% CI 0.88, 1.16; P = 0.79; HR 1.00, 95% CI 0.92, 1.09;
P = 0.89, respectively). However, an increase in dyspnoea
over both 7 and 14 days (HR 5.89, 95% CI 1.73, 20.04;
P < 0.004; HR 3.67, 95% CI 1.15, 11.70; P < 0.03; respec-
tively) was associated with a greater number of hospital ad-
missions (Table 2). The presence of peripheral oedema was
not significantly associated with greater risk for hospital ad-
mission (HR 0.89, 95% CI 0.27, 2.92; P = 0.85).
Discussion
These data do not support the common wisdom that a rapid
5 lb body-weight gain is associated with increased risk of
hospital readmission. Nonetheless, a rapid weight gain was
associated with increased risk of ED visits. We speculate that
there was a lower risk of office visits in association with body-
weight gain because patients had likely presented to the ED
instead of calling their provider. Novel to this study is a
side-by-side comparison of body-weight gain and HF
symptoms in relation to HF outcomes. Surprisingly, dyspnoea,
a subjective symptom with high prevalence in HF partici-
pants, better predicted ED visits and hospital admission in
comparison with a 5 lb weight gain. Unique to this study is
that diary use spanned over a lengthy 24 month period. We
found that higher diary use was associated with older age,
non-sedentary behaviour, less depression, and lower HF
knowledge.
Body-weight gain
The increase in body weight is used by disease management
programmes as a marker of HF decompensation.2 Our data
are in contrast from data obtained from a nested case–
control study that demonstrated 134 matched case patients
experienced body-weight gain 1 week prior to hospitaliza-
tion.18 However, these retrospective data do not determine
that weight gain was the cause of hospital admission. HF
symptoms such as dyspnoea or ED visit rates prior to hospital
admission were not examined, making a comparison with our
data not possible. In another study, investigators hypothe-
sized that daily electronic transmission of body weight would
reduce cardiac hospitalization for HF patients.19 Patients in
the intervention group were given an electronic scale, and
body weight was automatically transmitted and monitored
via the HF clinic. Electronic body-weight monitoring did not
decrease hospitalization rates.
Data demonstrate that not all HF hospital admissions are
associated with patients’ weight gain.20 In one study, investi-
gators compared a simple rule of thumb algorithm (i.e. 3 lb
weight gain in 1 day and 5 lb weight gain in 3 days) to a
moving average convergence divergence algorithm to predict
episodes of HF exacerbation and hospital admission.20
Although body-weight gain occurred within the 14 days prior
to hospital admission, the rule of thumb algorithm had a
much higher false alert rate. The investigators found that
the rule of thumb algorithm did not have great value, as
many episodes of worsening HF were not associated with
an increase of body weight.
Investigators also studied the optimal method to evaluate
body-weight monitoring adherence and found that self-
reported recall of weight monitoring adherence was not asso-
ciated with fewer HF hospitalizations.12 However, hand-diary
recorded adherence of ≥80% was associated with fewer HF-
related hospitalizations. HF patients tested a home-based
tablet computer system designed to improve self-care behav-
iours such as daily weighing.21 At hospital discharge, patients
were instructed to record daily body weights and received
lifestyle advice via tablet computer at home. Changes in
patient body weight were visible on the tablet over time
and resulted in improved self-care and decreased hospital
days. It is unclear whether the patient action of weighing
and hand recording their own body weight in a diary or tablet
can trigger more attention to self-care, thereby decreasing HF
hospitalization rates. There are qualitative data that suggest
purposeful reflection may be necessary for the development
of self-care skills.22
Because most HF exacerbations result in hospital admis-
sion,23 our data suggest that the patients in our study who
presented to the ED with a 5 lb body-weight gain did not
have an HF exacerbation or were readily treated for HF and
discharged. An increase in body weight by 5 lb over 7 days
demonstrated a lower risk for office visits. We speculate that
when HF patients experienced a weight gain, they presented
to the ED rather than to their local provider for care. No data
provide guidance on whether a 5 lb weight gain can have the
same effect on patients with different body mass index. For
example, does a 5 lb weight gain cause exacerbation of HF,
in a person who weighs 125 vs. 250 lb? Further studies are
needed to determine the effect of weight gain on the clinical
course of HF patients with various body sizes.
Heart failure signs and symptoms
Our data show that dyspnoea rather than body-weight gain
was a better predictor of unplanned office, ED visits, and hos-
pital admissions. Few investigators have examined HF
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symptoms as predictors of hospital admissions, but data from
the EVEREST trial describe dyspnoea during and after hospi-
talization.24 Daily assessment of dyspnoea was rated by both
physicians and patients to guide timing of discharge.
Physician-rated dyspnoea symptoms differed from patient-
reported dyspnoea, with decreases in dyspnoea during the
hospital treatment much more dramatic as assessed by phy-
sicians than patients. In-hospital dyspnoea ratings by both
patients and physicians were not found to be independently
associated with HF readmission. However, these data do not
examine dyspnoea rating before a hospitalization event. In-
vestigators did find in a group of hospitalized HF patients that
dyspnoea did predict short-term cardiac event-free survival.25
Another group of investigators found that survival rates were
improved with diary use that included daily body-weight
monitoring, but hospital readmission rates were not re-
ported.26 Our data show that increases in dyspnoea for
14 days did confer an increased risk for an office visit. This
suggests that patients contacted their provider as they per-
ceived a worsening of symptoms.
The mechanism of dyspnoea in HF exacerbations is related
to fluid retention, which is typically accompanied by an in-
crease of body weight. One explanation for our data that
showed body-weight gain was not associated with hospital
admission but dyspnoea symptoms were is that dyspnoea
may precede body-weight gain and/or be a more sensitive
predictor of HF exacerbation than weight gain.
Limitations
Our study has important limitations to consider. The sample
size is small and may lack the power to detect outcomes.
However, it is the largest study to include daily diary data
over a 2 year time period from rural HF patients. Patterns
of care in rural areas may differ from those in other geo-
graphic areas; therefore, external generalizability may be lim-
ited. Future studies that include a comparison of rural,
suburban, and urban HF patients will provide more informa-
tion. Participants who used the diaries were non-randomized;
thus, we cannot determine causality. Not all participants used
the dairies on a daily basis. We did not include dietary,
medication, or exercise habits of HF patients, making the in-
fluence of dietary intake, exercise, or medication adjustment
unknown. We did not include baseline pulmonary disease co-
morbidities, making the influence of alternative causes of
acute dyspnoea unknown. Diary use may have been influ-
enced by participants who were more healthy overall.
Conclusions
Despite the common wisdom that a 5 lb weight gain is asso-
ciated with hospital admission, our data do not support this.
A 5 lb weight gain was associated with increased risk of ED
visits, but these ED visits may not represent HF exacerba-
tions. Dyspnoea was a better predictor of increased office
visits, ED visits, and hospital admissions. Guidelines support
self-management as a strategy to improve HF outcomes.
The use of diaries is one cost-effective method to track clini-
cal symptoms and body weight of HF patients. However, dys-
pnoea may be the more important data to track to prevent
HF hospitalization. A prospective randomized controlled trial
is needed to definitively determine if a 5 lb body-weight gain
in 7 days increases risk for hospital admission, because this
recommendation is a central educational topic in HF patients.
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